BRIGHT MINDS BIOSCIENCES INC (DRUG) Stock Analyst Ratings
USA - NASDAQ:DRUG - CA10919W4056 - Common Stock
59.29 USD
+1 (+1.72%)
ChartMill assigns a Buy % Consensus number of 86% to DRUG. The Buy consensus is the weighted average rating of the current analysts ratings.
DRUG was analyzed by 7 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about DRUG.
In the previous month the buy percentage consensus was at a similar level.
DRUG was analyzed by 7 analysts. More opinions would make the average more meaningful.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-09-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-09-08 | BTIG | Initiate | Buy |
| 2025-08-19 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-05-21 | Chardan Capital | Maintains | Buy -> Buy |
| 2025-05-13 | TD Cowen | Initiate | Buy |
| 2025-05-07 | Chardan Capital | Initiate | Buy |
| 2025-02-19 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-23 | Piper Sandler | Initiate | Overweight |
| 2025-01-10 | Cantor Fitzgerald | Initiate | Overweight |
| 2025-01-10 | HC Wainwright & Co. | Initiate | Buy |
| 2024-11-25 | Baird | Initiate | Outperform |
BRIGHT MINDS BIOSCIENCES INC / DRUG FAQ
What is the consensus rating for BRIGHT MINDS BIOSCIENCES INC (DRUG) stock?
The consensus rating for BRIGHT MINDS BIOSCIENCES INC (DRUG) is 85.7143 / 100 . This indicates that analysts generally have a positive outlook on the stock.
What is the number of analysts for DRUG stock?
The number of analysts covering BRIGHT MINDS BIOSCIENCES INC (DRUG) is 7.